Business Description
BioForce Nanosciences Holdings Inc
NAICS : 311999
SIC : 2099
ISIN : US09064C2061
Total Employee Number:
3Compare
Compare
Traded in other countries / regions
BFNH.USA IPO Date
2004-03-16Description
BioForce Nanosciences Holdings Inc is a provider of natural vitamins, minerals, and other nutritional supplements, powders, and beverages. It markets its products through social media and telemarketing. BioForce currently markets its products through social media and telemarketing. Nutrition retailers, grocery stores, retail pharmacies, and online stores, like Amazon, will be important channels for the Company's Eclipse product-lines.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | -120.17 | |||||
Interest Coverage | No Debt | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 4.1 | |||||
3-Year EPS without NRI Growth Rate | 7.2 | |||||
3-Year Book Growth Rate | 26.9 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 17.05 | |||||
9-Day RSI | 33.3 | |||||
14-Day RSI | 42.93 | |||||
3-1 Month Momentum % | 294.62 | |||||
6-1 Month Momentum % | 209.69 | |||||
12-1 Month Momentum % | 231.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.01 | |||||
Quick Ratio | 0.01 | |||||
Cash Ratio | 0.01 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -4.6 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROA % | -10000 | |||||
ROIC % | -115.12 | |||||
3-Year ROIIC % | 0.6 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
EV-to-EBIT | -91.81 | |||||
EV-to-EBITDA | -91.81 | |||||
EV-to-FCF | -1014.14 | |||||
Earnings Yield (Greenblatt) % | -1.09 | |||||
FCF Yield % | -0.1 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:BFNH
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
BioForce Nanosciences Holdings Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | 2.715 | ||
| 3-Year Sharpe Ratio | 0.62 | ||
| 3-Year Sortino Ratio | 1.42 | ||
| Volatility % | 195.43 | ||
| 14-Day RSI | 42.93 | ||
| 14-Day ATR ($) | 0.260188 | ||
| 20-Day SMA ($) | 1.689645 | ||
| 12-1 Month Momentum % | 231.48 | ||
| 52-Week Range ($) | 0.18 - 2.05 | ||
| Shares Outstanding (Mil) | 33.55 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
BioForce Nanosciences Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
BioForce Nanosciences Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-11-19 | In 128 days | ||
| Second quarter earnings results for 2026 | 2026-08-11 | In 28 days | ||
| General meeting for 2025 | 2026-07-13 | 1.79 (-12.30%) | ||
| First quarter earnings results for 2026 | 2026-05-19 | 0.55 (-33.14%) | ||
| Annual report for 2025 | 2026-04-15 | 0.45 (+0.00%) | ||
| Third quarter earnings results for 2025 | 2025-11-19 | 0.60 (+0.00%) | ||
| Second quarter earnings results for 2025 | 2025-08-11 | 0.84 (+65.25%) | ||
| First quarter earnings results for 2025 | 2025-05-13 | 0.53 (+0.00%) | ||
| Annual report for 2024 | 2025-04-08 | 0.56 (+0.00%) | ||
| Third quarter earnings results for 2024 | 2024-11-08 | 1.05 (+0.00%) |
Show
Entries
BioForce Nanosciences Holdings Inc Frequently Asked Questions
What is BioForce Nanosciences Holdings Inc(BFNH)'s stock price today?
The current price of BFNH is $1.30. The 52 week high of BFNH is $2.05 and 52 week low is $0.18.
When is next earnings date of BioForce Nanosciences Holdings Inc(BFNH)?
The next earnings date of BioForce Nanosciences Holdings Inc(BFNH) is 2026-08-11 Est..
Does BioForce Nanosciences Holdings Inc(BFNH) pay dividends? If so, how much?
BioForce Nanosciences Holdings Inc(BFNH) does not pay dividend.
Guru Commentaries on OTCPK:BFNH
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on BioForce Nanosciences Holdings Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers